21 related articles for article (PubMed ID: 17380322)
1. Lifestyle Cardiovascular Risk Score, Genetic Risk Score, and Myocardial Infarction in Hispanic/Latino Adults Living in Costa Rica.
Sotos-Prieto M; Baylin A; Campos H; Qi L; Mattei J
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27998913
[TBL] [Abstract][Full Text] [Related]
2. Diet-Attributable Greenhouse Gas Emissions and Acute Myocardial Infarction in Costa Rica Heart Study.
Aljahdali AA; Campos H; Granados K; Jones AD; Baylin A
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201967
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
[TBL] [Abstract][Full Text] [Related]
4. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B
Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
6. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ
Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221
[TBL] [Abstract][Full Text] [Related]
7. Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Nisa H; Budhathoki S; Morita M; Toyomura K; Nagano J; Ohnaka K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
Mol Carcinog; 2013 Aug; 52(8):619-26. PubMed ID: 22415791
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction.
Cornelis MC; El-Sohemy A; Campos H
J Med Genet; 2004 Oct; 41(10):758-62. PubMed ID: 15466009
[TBL] [Abstract][Full Text] [Related]
9. EPHX1 polymorphisms and the risk of lung cancer: a HuGE review.
Kiyohara C; Yoshimasu K; Takayama K; Nakanishi Y
Epidemiology; 2006 Jan; 17(1):89-99. PubMed ID: 16357600
[TBL] [Abstract][Full Text] [Related]
10. Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.
Václavíková R; Hughes DJ; Souček P
Gene; 2015 Oct; 571(1):1-8. PubMed ID: 26216302
[TBL] [Abstract][Full Text] [Related]
11. Microsomal epoxide hydrolase genotype and risk of myocardial infarction.
Cornelis MC; El-Sohemy A; Campos H
Arch Toxicol; 2007 Sep; 81(9):641-5. PubMed ID: 17380322
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
